149 related articles for article (PubMed ID: 21300921)
1. Targeting epidermal growth factor receptor to optimize chemoradiotherapy in locally advanced head and neck cancer: has biology been taken into account?
Herchenhorn D; Ferreira CG
J Clin Oncol; 2011 Apr; 29(10):e283-4; author reply e285-7. PubMed ID: 21300921
[No Abstract] [Full Text] [Related]
2. Combination therapy with bevacizumab and temsirolimus in squamous cell carcinoma of the head and neck.
Bhatt VR; Ganti AK
Oral Oncol; 2013 Aug; 49(8):e25. PubMed ID: 23631847
[No Abstract] [Full Text] [Related]
3. Treatment of advanced head and neck cancer: what lessons have we learned?
Conley BA
J Clin Oncol; 2006 Mar; 24(7):1023-5. PubMed ID: 16505419
[No Abstract] [Full Text] [Related]
4. Integrating novel agents into the curative treatment of head and neck cancer.
Haddad R; Allen A; Wirth L; Tishler R; Posner M
Expert Rev Anticancer Ther; 2006 Feb; 6(2):157-9. PubMed ID: 16445367
[No Abstract] [Full Text] [Related]
5. [Role of targeted therapy in the treatment of squamous cell head and neck cancer].
Gyergyay F
Magy Onkol; 2007; 51(2):155-7. PubMed ID: 17660872
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of combined treatment with cetuximab (erbitux) and radiation therapy in patients with head and neck cancer.
Koukourakis G; Kouloulias V; Koukourakis M; Kouvaris J; Zacharias G; Gouliamos A
J BUON; 2009; 14(1):19-25. PubMed ID: 19373942
[TBL] [Abstract][Full Text] [Related]
7. A multidisciplinary approach to squamous cell carcinomas of the head and neck: an update.
Bernier J
Curr Opin Oncol; 2008 May; 20(3):249-55. PubMed ID: 18391622
[TBL] [Abstract][Full Text] [Related]
8. [Radio-chemotherapy in head and neck cancer (EGFR+)].
Ozsahin M; Matzinger O; Zimmermann M; Zouhair A
Bull Cancer; 2007 Sep; 94(9):828-32. PubMed ID: 17878104
[TBL] [Abstract][Full Text] [Related]
9. Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigm.
Pfister DG; Su YB; Kraus DH; Wolden SL; Lis E; Aliff TB; Zahalsky AJ; Lake S; Needle MN; Shaha AR; Shah JP; Zelefsky MJ
J Clin Oncol; 2006 Mar; 24(7):1072-8. PubMed ID: 16505426
[TBL] [Abstract][Full Text] [Related]
10. [Head and neck: molecular-targeted therapy].
Tsukuda M
Gan To Kagaku Ryoho; 2007 Jul; 34(7):1034-9. PubMed ID: 17682304
[No Abstract] [Full Text] [Related]
11. Targeting the future in head and neck cancer.
Brizel DM
Lancet Oncol; 2009 Mar; 10(3):204-5. PubMed ID: 19261251
[No Abstract] [Full Text] [Related]
12. Intensive concomitant chemoradiotherapy in locally advanced unresectable squamous cell carcinoma of the head and neck: a phase II study of radiotherapy with cisplatin and 7-week continuous infusional fluorouracil.
Wibault P; Bensmaine MA; de Forni M; Armand JP; Tellez Bernal E; Guillot T; Recondo G; Domenge C; Janot F; Borel C; Luboinski B; Eschwege F; Cvitkovic E
J Clin Oncol; 1996 Apr; 14(4):1192-200. PubMed ID: 8648374
[TBL] [Abstract][Full Text] [Related]
13. Head and neck cancer: integrating anti-EGFR treatment with standard therapy.
Kies MS
J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 2():S52-9. PubMed ID: 19780246
[TBL] [Abstract][Full Text] [Related]
14. [Use of docetaxel in treatment of squamous-cell carcinoma of head and neck].
Subramanian S; Kanagavel D; Petenko NN; Orlova KV; Samoĭlenko IV; Demidov LV
Vopr Onkol; 2011; 57(4):421-6. PubMed ID: 22191228
[No Abstract] [Full Text] [Related]
15. Is there a new role for induction chemotherapy in the treatment of head and neck cancer?
Forastiere AA
J Natl Cancer Inst; 2004 Nov; 96(22):1647-9. PubMed ID: 15547172
[No Abstract] [Full Text] [Related]
16. Enhancement of radiosensitivity in head and neck cancer cells by ZD1839 ('IRESSA'), a selective epidermal growth factor receptor tyrosine kinase inhibitor.
Shintani S; Kiyota A; Mihara M; Sumida T; Kayahara H; Nakashiro K; Hamakawa H
Am J Clin Oncol; 2003 Oct; 26(5):e150-6. PubMed ID: 14528090
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of docetaxel-induced cytotoxicity by blocking epidermal growth factor receptor and cyclooxygenase-2 pathways in squamous cell carcinoma of the head and neck.
Choe MS; Chen Z; Klass CM; Zhang X; Shin DM
Clin Cancer Res; 2007 May; 13(10):3015-23. PubMed ID: 17505004
[TBL] [Abstract][Full Text] [Related]
18. A new look at induction chemotherapy in locally advanced head and neck cancer.
Vermorken JB
Oncologist; 2010; 15 Suppl 3():1-2. PubMed ID: 21036881
[No Abstract] [Full Text] [Related]
19. Role of epidermal growth factor receptor pathway-targeted therapy in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Cohen EE
J Clin Oncol; 2006 Jun; 24(17):2659-65. PubMed ID: 16763280
[TBL] [Abstract][Full Text] [Related]
20. Phase I/II study of docetaxel, cisplatin, and concomitant boost radiation for locally advanced squamous cell cancer of the head and neck.
Tsao AS; Garden AS; Kies MS; Morrison W; Feng L; Lee JJ; Khuri F; Zinner R; Myers J; Papadimitrakopoulou V; Lewin J; Clayman GL; Ang KK; Glisson BS
J Clin Oncol; 2006 Sep; 24(25):4163-9. PubMed ID: 16943532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
